Biochemical Activities of main Group Metal Chelates of Curcuminoid Analogues
DOI:
https://doi.org/10.7439/ijbar.v6i4.1928Abstract
Turmeric and its active chemical constituents, curcuminoids, have been reported to possess a number of medicinal uses particularly in the treatment of inflammation, angiogenesis, tumorigenesis, diabetes etc. Structurally, curcuminoids are 1,7-diaryl-1,6-heptadiene-3,5-diones and are known to form metal complexes similar to other 1,3diketones. It has been reported that metal complexation of these ?, ?,-unsaturated 1,3-diketones lead to dramatic changes in their biochemical activities including antitumour, antimicrobial and antioxidant activity. The two new curcuminoid analogues namely 1,7-bis(2,5-dimethyl phenyl) hepta-1,6-diene-3,5-dione and 1,7-bis(2,4-dihydroxy phenyl)hepta-1,6-diene-3,5-dione have been synthesized and were complexed with main group metals Al(III), Ga(III) and In(III). They were characterized by IR, UV, 1 H NMR, 13 CNMR and Mass spectral techniques. In vitro cytotoxic studies were done with ligand and metal complexes (Al,Ga and In) against DLA and EAC cells using Tryptan blue exclusion method and antibacterial study of the compounds were done using agar well diffusion method. The in vivo antitumour activity of the ligand and complexes were determined by using DLA cells in mice and compared with standard anticancer drug cyclophosphamideDownloads
References
Chainani-Wu N. Safety and Anti-Inflammatory Activity of Curcumin. J. Altern. Complement. Med. 2003.
Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig. Dis. Sci. 2005; 50.
Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad. Sci 2005; 1056.
Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur. J. Cancer. 2005; 41.
Sreejayan N, Rao MNA. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 1994; 46.
Subramanian M, Sreejayan N, Rao MNA, Devasagayam TDA,Singh BB. Diminution of singlet oxygen-induced DNA-Damage by curcumin and related antioxidants. Mutat Res. 1994; 311.
Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and Phase II metabolizing enzymes in ddy male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol. 2003; 1: 92.
Kuo ML, Huang TS, Lin JK. Curcumin, an antioxidant and anti-tumour promoter. Biochim. Biophys. Acta. 1996; 2: 1317.
Leu TH, Maa MC, The Molecular mechanism for the Antitumorigenic effect of curcumin Curr. Med. Chem. Anti-canc Agents. 2000; 2.
Kostova D, Albena T, Paul T. Relation of structure of curcumin analogues to their potencies as inducers of phase-2 detoxification enzymes. Carcinogenesis. 1999; 20 : 911-919.
Krishnankutty K, John VD. Synthesis, characterization and antitumour studies of metal chelates of some synthetic curcuminoids. Synhesis and Reactivity in Inorganic Metal-Organic Chemistry. 2003; 33: 343-358.
Krishnankutty K, John VD, Kuttan G. Antitumour studies of metal chelates of synthetic curcuminoids. Journal of Experimental and Clinical Cancer Research. 2002; 21: 219-224
Krishnankutty K, Venugopalan P. Metal chelates of curcuminoids. Synthesis and Reactivity in Inorganic Metal-Organic Chemistry. 1998; 28:1313-1325.
Sharma KK, Chandra S, Babu DK. Synthesis and anti arthritic study of a new orally active curcumin gold complex. Inorganica Chimica Acta. 1987; 135: 47-48.
Clare MJ, Hydes DC . In: Sigel H (Ed.). Metal ions in biological systems, metal complexes as anticancer drugs. Marcel Decker, New York: 1979. p. 1-62.
Pabon HJJ. A synthesis of curcumin and related compounds. Recueil des Travaux Chimiques des Pays-Bas. 1964; 83: 237-240.
Kuttan G, Vasudevan DM, Kuttan R . Isolation and identification of a tumour reducing component from mistletoe extract. Cancer Letters. 1988; 41: 307-315.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).